2023 seems difficult for everyone and the pharma industry is getting the same vibe of economic slowness and lack of demand. As a result, Amgen has also laid off 300 employees along the commercial lines.

The company spokesperson shared, “We made these changes to better manage against industry headwinds so that we can continue to deliver value for our patients, staff, and shareholders. These decisions are never easy, and we are committed to helping those impacted with transitional support."

This is not the first episode of pharma lay-off in 2023, previously it was Abzena.’The company had to let go of 66 employees. However, many people are speculating that this massive removal is an outcome of the newly hired CEO in January.